Immunosuppression during acute Trypanosoma cruzi infection: Involvement of Ly6G (Gr1+)CD11b+ immature myeloid suppressor cells

International Immunology

Volumn 14, Issue 10, 2002, Pages 1125-1134

  Goñi, Oscar ^a   Alcaide, Pilar ^a   Fresno, Manuel ^a  

^a CSIC   (Spain)

Author keywords

Cytokines; Nitric oxide; Parasitic protozoan; Suppression; T lymphocyte

Indexed keywords

CD11B ANTIGEN; CD69 ANTIGEN; CONCANAVALIN A; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 5; LYMPHOCYTE SURFACE MARKER; MITOGENIC AGENT; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTIGEN PURIFICATION; ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CELL STIMULATION; CHAGAS DISEASE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DOWN REGULATION; IMMUNE DEFICIENCY; INTERFERON PRODUCTION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; SUPPRESSOR CELL; T LYMPHOCYTE ACTIVATION; TRYPANOSOMA CRUZI;

ACUTE DISEASE; ANIMALS; ANTIGENS, CD11B; ANTIGENS, LY; CHAGAS DISEASE; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-2; MICE; MICE, INBRED C57BL; NITRIC OXIDE; RECEPTORS, INTERLEUKIN-2; SPLEEN; T-LYMPHOCYTES, REGULATORY;

EID: 0036798269     PISSN: 09538178     EISSN: None     Source Type: Journal    
DOI: 10.1093/intimm/dxf076     Document Type: Article

References (40)

1. Tanowitz, H. B. Kirchhoff, L. V., Simon, D., Morris, S. A., Weiss, L. M. and Wittner, M. 1992. Chagas' disease. Clin. Microbiol. Rev. 5:400.
2. 2+-Signaling factor for mammalian cells. J. Biol. Chem. 270:5172.
3. Kierszenbaum, F. 1982, Immunologic deficiency during experimental Chagas' disease (Trypanosoma cruzi infection): role of adherent, nonspecific esterase-positive splenic cells. J. Immunol. 129:2202.
4. Cetron, M. S., Basilio, F. P., Moraes, A. P., Sousa, A. Q., Paes, J. N., Kahn, S. J., Wener, M. H. and Van Voorhis, W. C. 1993. Humoral and cellular immune response of adults from northeastern Brazil with chronic Trypanosoma cruzi infection: depressed cellular immune response to T. cruzi antigen among Chagas' disease patients with symptomatic versus indeterminate infection. Am. J. Trop. Med. Hyg. 49:370.
5. Tarleton, R. L. 1988. Trypanosoma cruzi-induced suppression of IL-2 production. II. Evidence for a role for suppressor cells. J. Immunol. 140:2769.
6. Lopes, M. F. and dos Reis, G. A. 1994. Trypanosoma cruzi-induced immunosuppression: blockade of costimulatory T-cell responses in infected hosts due to defective T-cell receptor-CD3 functioning. Infect. Immun. 62:1484.
7. Cardillo, F., Nomizo, A. and Mengel, J. 1998. The role of the thymus in modulating gammadelta T cell suppressor activity during experimental Trypanosoma cruzi infection. Int. Immunol. 10:107.
8. Motran, C., Gruppi, A., Vullo, C. M., Pistoresi-Palencia, M. C. and Serra, H. M. 1996. Involvement of accessory cells in the Trypanosoma cruzi-induced inhibition of the polyclonal response of T lymphocytes, Parasite Immunol. 18:43.
9. Harel-Bellan, A., Joskowicz, M., Fradelizi, D. and Eisen, H. 1983. Modification of T-cell proliferation and interleukin 2 production in mice infected with Trypanosoma cruzi. Proc. Natl Acad. Sci. USA 80:3466.
10. Cerrone, M. C., Ritter, D. M. and Kuhn, R. E. 1992. Effect of antigen-specific T helper cells or interleukin-2 on suppressive ability of macrophage subsets detected in spleens of Trypanosoma cruzi-infected mice as determined by limiting dilution- partition analysis, Infect. Immun. 60:1489.
11. Harel-Bellan, A., Joskowicz, M., Fradelizi, D. and Eisen, H. 1985. T lymphocyte function during experimental Chagas' disease: production of and response to interleukin 2. Eur. J. Immunol. 15:438.
12. Lopez, H. M., Tanner, M. K., Kierszenbaum, F. and Sztein, M. B. 1993. Alterations induced by Trypanosoma cruzi in activated mouse lymphocytes. Parasite Immunol. 15:273.
13. Kierszenbaum, F., Lopez, H. M. and Sztein, M. B. 1994. Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease. Immunology 81:462.
14. Tarleton, R. L. 1988. Tumour necrosis factor (cachectin) production during experimental Chagas' disease. Clin. Exp. Immunol. 73:186.
15. Nabors, G. S. and Tarleton, R. L. 1991. Differential control of IFN-gamma and IL-2 production during Trypanosoma cruzi infection. J. Immunol. 146:3591.
16. Abrahamsohn, I. A. and Coffman, R. L. 1995. Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. J. Immunol. 155:3955.
17. + T lymphocytes from infected hosts. J. Immunol. 160:1313.
18. Martins, G. A., Cardoso, M. A., Aliberti, J. C. and Silva, J. S. 1998. Nitric oxide-induced apoptotic cell death in the acute phase of Trypanosoma cruzi infection in mice. Immunol. Lett. 63:113.
19. Fernandez-Gomez, R., Esteban, S., Gomez-Corvera, R., Zoulika, K. and Ouaissi, A. 1998. Trypanosoma cruzi:. Tc52 released protein-induced increased expression of nitric oxide synthase and nitric oxide production by macrophages. J. Immunol. 160:3471.
20. Hansen, D. S., Villacres-Eriksson, M., Akerblom, L., Hellman, U., Segura, E., Carlomagno, M. and Morein, B. 1998. An immunoaffinity-purified Trypanosoma cruzi antigen suppresses cellular proliferation through a TGF-beta-mediated mechanism, Scand. J. Immunol. 47:509.
21. Pinge-Filho, P., Tadokoro, C. E. and Abrahamsohn, I. A. 1999. Prostaglandins mediate suppression of lymphocyte proliferation and cytolkine synthesis in acute Trypanosoma cruzi infection. Cell. Immunol. 193:90.
22. Sher, A. and Coffman, R. L. 1992. Regulation of immunity to parasites by T cells and T cell-derived cytokines. Annu. Rev. Immunol. 10:385.
23. Fresno, M., Kopf, M. and Rivas, L. 1997. Cytokines and infectious diseases. Immunol. Today 18:56.
24. Aliberti, J. C., Cardoso, M. A., Martins, G. A., Gazzinelli, R. T., Vieira, L. Q. and Silva, J. S. 1996. Interleukin-12 mediates resistance to Trypanosoma cruzi in mice and is produced by murine macrophages in response to live trypomastigotes. Infect. Immun. 64:1961.
25. MunÌ�oz-FernaÌndez, M. A., Fernandez, M. A. and Fresno, M. 1992. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur. J. Immunol. 22:301.
26. Gazzinelli, R. T., Oswald, I. P., Hieny, S., James, S. L. and Sher, A. 1992. The microbicidal activity of interferon-gamma-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, nitrogen oxide-mediated mechanism inhibitable by interleukin-10 and transforming growth factor-beta. Eur. J. Immunol. 22:2501.
27. Silva, J. S., Morrissey, P. J., Grabstein, K. H., Mohler, K. M., Anderson, D. and Reed, S. G. 1992. Interleukin 10 and interferon gamma regulation of experimental Trypanosoma cruzi infection. J. Exp. Med. 175:169.
28. Torrico, F., Heremans, H., Rivera, M. T., Van Marck, E., Billiau, A. and Carlier, Y. 1991. Endogenous IFN-gamma is required for resistance to acute Trypanosoma cruzi infection in mice. J. Immunol. 146:3626.
29. Lima, E. C., Garcia, I., Vicentelli, M. H., Vassalli, P. and Minoprio, P. 1997. Evidence for a protective role of tumor necrosis factor in the acute phase of Trypanosoma cruzi infection in mice. Infect. Immun. 65:457.
30. Petray, P. B., Rottenberg, M. E., Bertot, G., Corral, R. S., Diaz, A., Orn, A. and Grinstein, S. 1993. Effect of anti-gamma-interferon and anti-interleukin-4 administration on the resistance of mice against infection with reticulotropic and myotropic strains of Trypanosoma cruzi. Immunol. Lett. 35:77.
31. Alcina, A. and Fresno, M. 1987. A colorimetric assay based on cell viability for the indirect detection of intracellular replication and killing of Trypanosoma cruzi. J. Immunol. Methods 105:1.
32. Tarleton, R. L. and Kuhn, R. E. 1983. Changes in cell populations and immunoglobulin-producing cells in the spleens of mice infected with Trypanosoma cruzi. correlations with parasite-specific antibody response. Cell. Immunol. 80:392.
33. - T cells in the polyclonal lymphocyte responses to murine T. cruzi infection. Int. Immunol. 1:176.
34. + myeloid cells derived from tumor-bearing mice inhibit primary T cell activation induced through CD3/CD28 costimulation. J. Immunol. 165:779.
35. + cells in the spleen of cyclophosphamide-treated mice: implications for T-cell responses in immunosuppressed mice. Blood 95:212.
36. Millar, A. E. and Kahn, S. J. 2000. Trypanosoma cruzi: the effect of nitric oxide synthesis inhibition on the CD4 T cell response to the trans-sialidase superfamily. Exp. Parasitol. 94:84.
37. + cells. J. Immunol. 161:5313.
38. Flaishon, L., Hershkoviz, R., Lantner, F., Lider, O., Alon, R., Levo, Y., Flavell, R. A. and Shachar, I. 2000. Autocrine secretion of interferon gamma negatively regulates homing of immature B cells. J. Exp. Med. 192:1381.
39. Allione, A., Bernabei, P., Bosticardo, M., Ariotti, S., Forni, G. and Novelli, F. 1999. Nitric oxide suppresses human T lymphocyte proliferation through IFN-gamma-dependent and IFN-gamma-independent induction of apoptosis. J. Immunol. 163:4182.
40. Holscher, C., Kohler, G., Muller, U., Mossmann, H., Schaub, G. A. and Brombacher, F. 1998. Defective nitric oxide effector functions lead to extreme susceptibility of Trypanosoma cruzi-infected mice deficient in gamma interferon receptor or inducible nitric oxide synthase. Infect. Immun. 66:1208.